STAT+: Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more
STAT
JUNE 27, 2025
If the weather does not cooperate, there is always a good book or the telly. Packages valued at less than $800 that enter the U.S. Centers for Disease Control and Prevention on vaccines voted to recommend the use of a new monoclonal antibody against RSV in babies, Merck’s Enflonsia , STAT tells us. But be safe.
Let's personalize your content